###begin article-title 0
Regulation of p110delta PI 3-Kinase Gene Expression
###end article-title 0
###begin p 1
Conceived and designed the experiments: KK GEN EAGV BV. Performed the experiments: KK GEN EAGV. Analyzed the data: KK GEN EAGV MPP BV. Contributed reagents/materials/analysis tools: DWH MPP. Wrote the paper: KK GEN EAGV MPP BV. Bioinformatic analysis: MPM.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Despite an intense interest in the biological functions of the phosphoinositide 3-kinase (PI3K) signalling enzymes, little is known about the regulation of PI3K gene expression. This also applies to the leukocyte-enriched p110delta catalytic subunit of PI3K, an enzyme that has attracted widespread interest because of its role in immunity and allergy.
###end p 3
###begin title 4
Principal Findings
###end title 4
###begin p 5
###xml 821 826 <span type="species:ncbi:9606">human</span>
###xml 898 903 <span type="species:ncbi:10090">mouse</span>
We show that p110delta expression is mainly regulated at the transcriptional level. In fibroblasts, lymphocytes and myeloid cells, p110delta gene transcription appears to be constitutive and not subject to acute stimulation. 5'RACE experiments revealed that p110delta mRNA transcripts contain distinct upstream untranslated exons (named exon -1, -2a, -2b, -2c and -2d), which are located up to 81 kb upstream of the translational start codon in exon 1. The levels of all the different p110delta transcripts are higher in leukocytes compared to non-leukocytes, with the p110delta transcript containing exon -2a most abundantly expressed. We have identified a highly conserved transcription factor (TF) binding cluster in the p110delta gene which has enhanced promoter activity in leukocytes compared to non-leukocytes. In human, this TF cluster is located immediately upstream of exon -2a whilst in mouse, it is located within exon -2a.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 34 40 34 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3CD</italic>
This study identifies a conserved PIK3CD promoter region that may account for the predominant leukocyte expression of p110delta.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 214 217 214 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Vanhaesebroeck1">[1]</xref>
Phosphoinositide 3-kinases (PI3Ks) generate lipid second messengers that regulate a broad variety of cellular responses such as growth, cell cycle progression, differentiation, vesicular traffic and cell migration [1]. PI3K activity is critical in a wide variety of normal and pathological physiological responses, including immune regulation, metabolic control and cancer. However, despite the importance of this signalling system, very little is known about the regulation of PI3K gene expression under normal and disease conditions.
###end p 9
###begin p 10
###xml 42 45 42 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Vanhaesebroeck2">[2]</xref>
###xml 586 600 575 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3CA, PIK3CB</italic>
###xml 605 611 594 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3CD</italic>
###xml 773 779 750 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3R1</italic>
###xml 823 829 793 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3R2</italic>
###xml 834 840 804 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3R3</italic>
###xml 943 946 909 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Krugmann1">[3]</xref>
###xml 948 951 914 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Stephens1">[4]</xref>
###xml 959 962 925 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Suire1">[5]</xref>
###xml 964 967 930 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Voigt1">[6]</xref>
###xml 1108 1111 1059 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Vanhaesebroeck1">[1]</xref>
###xml 1113 1116 1064 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-GuillermetGuibert1">[7]</xref>
###xml 1117 1120 1068 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Ciraolo1">[9]</xref>
The PI3K family is divided into 3 classes [2]. Class I PI3Ks are acutely activated upon receptor stimulation and are heterodimers consisting of a p110 catalytic subunit in complex with a regulatory subunit. The class I PI3Ks are further subdivided into class IA and IB, depending on whether the catalytic subunit is in complex with an SH2-domain containing regulatory subunit (collectively called 'p85') or with the p101 or p84 regulatory subunits, which lack SH2 domains. Mammals have 3 class IA p110 catalytic subunits, p110alpha, p110beta and p110delta, encoded by 3 distinct genes, PIK3CA, PIK3CB and PIK3CD, respectively. These p110 isoforms interact with p85, of which there are at least five different species, called p85alpha, p55alpha and p50alpha (encoded by the PIK3R1 gene) and p85beta and p55gamma (encoded by PIK3R2 and PIK3R3, respectively). p110gamma is the only class IB PI3K catalytic subunit and occurs in complex with p101 [3], [4] or p84 [5], [6], which have no homology to p85. Class I PI3Ks can be activated by tyrosine kinases (p110alpha, p110delta) or GPCRs (p110beta and p110gamma) [1], [7]-[9].
###end p 10
###begin p 11
###xml 85 89 85 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Kok1">[10]</xref>
###xml 165 169 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Bi1">[11]</xref>
###xml 170 174 163 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Hu1">[15]</xref>
###xml 220 224 209 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Geering1">[12]</xref>
###xml 226 230 215 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Vanhaesebroeck3">[13]</xref>
###xml 232 236 221 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Chantry1">[16]</xref>
###xml 278 282 267 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Eickholt1">[17]</xref>
###xml 334 338 323 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Vanhaesebroeck3">[13]</xref>
###xml 340 344 329 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Sawyer1">[18]</xref>
###xml 570 574 555 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Sawyer1">[18]</xref>
###xml 679 683 656 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Hirsch1">[19]</xref>
###xml 684 688 661 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Li1">[21]</xref>
###xml 766 770 743 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Alloatti1">[22]</xref>
###xml 771 775 748 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Stoyanov1">[24]</xref>
###xml 795 799 772 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Puri1">[25]</xref>
###xml 819 823 796 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Li2">[26]</xref>
###xml 825 829 802 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-MacDonald1">[27]</xref>
###xml 854 858 831 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Vecchione1">[28]</xref>
Tissue distribution and the regulation of PI3K expression has recently been reviewed [10]. Whereas p110alpha and p110beta appear to have a broad tissue distribution [11]-[15], p110delta is highly expressed in leukocytes [12], [13], [16], found at intermediate levels in neurons [17] and present at low levels in most other cell types [13], [18]. p110delta is also expressed at moderate levels in some cancer cells of non-leukocyte origin such as melanoma and breast cancer cells, often with large differences in expression levels in cell lines of the same tissue origin [18], for reasons that are unclear at the moment. Like p110delta, p110gamma is highly enriched in leukocytes [19]-[21] but is also found at lower levels in other cell types such as cardiomyocytes [22]-[24], endothelial cells [25], pancreatic islets [26], [27] and smooth muscle cells [28].
###end p 11
###begin p 12
###xml 161 165 154 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Pankow1">[29]</xref>
###xml 192 196 181 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Ito1">[30]</xref>
###xml 198 202 187 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Okamoto1">[31]</xref>
###xml 245 249 227 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Northcott1">[32]</xref>
###xml 250 254 232 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Northcott3">[34]</xref>
###xml 437 441 415 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Andreelli1">[35]</xref>
###xml 442 446 420 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Lefai1">[39]</xref>
###xml 567 571 537 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Abell1">[40]</xref>
###xml 591 595 557 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Spender1">[41]</xref>
###xml 617 621 579 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Kallin1">[42]</xref>
###xml 692 696 647 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Park1">[43]</xref>
###xml 698 702 653 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Guo1">[44]</xref>
###xml 716 720 671 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Kok1">[10]</xref>
Expression of the class IA catalytic isoforms can be altered during physiological and pathological processes, including differentiation (p110alpha and p110beta) [29], regeneration (p110alpha) [30], [31] and hypertension (p110beta and p110delta) [32]-[34]. PI3K expression, especially of p110alpha, is also very frequently increased in cancer. Insulin and nuclear receptor ligands can induce expression of the class I regulatory subunits [35]-[39]. Other documented mechanisms of p85 regulation are through the transcription factors (TF) STAT3 (p55alpha and p50alpha) [40], EBNA-2 (p55alpha) [41] and SREBP (p55gamma) [42] and through targeted degradation of p85alpha and p85beta by microRNAs [43], [44] (reviewed in [10]).
###end p 12
###begin p 13
###xml 101 107 97 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3CA</italic>
###xml 113 119 109 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3CA</italic>
###xml 408 412 404 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Astanehe1">[45]</xref>
###xml 414 418 410 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Hui1">[46]</xref>
###xml 445 449 441 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Astanehe1">[45]</xref>
###xml 459 463 455 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Hui1">[46]</xref>
###xml 479 483 471 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Yang1">[47]</xref>
###xml 79 84 <span type="species:ncbi:9606">human</span>
Three recent studies have identified a transcription regulatory region for the human p110alpha gene, PIK3CA. The PIK3CA locus gives rise to two alternative transcripts which each contain a distinct 5' untranslated exon (exon -1b or -1a) that is spliced onto the first translated (ATG-containing) exon. The genomic position of these 5' untranslated exons is about 50 kb upstream of the translation start site [45], [46]. TF binding sites for p53 [45]), FOXO3a [46]) and NF-kappaB [47] have been mapped in close proximity to the most 5' untranslated exon (called exon -1b). Whereas p53 might inhibit transcription of p110alpha, evidence for a positive regulation by NF-kappaB and FOXO3a has been presented.
###end p 13
###begin p 14
###xml 64 68 60 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Hirsch1">[19]</xref>
###xml 497 501 485 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Hirsch1">[19]</xref>
###xml 674 678 658 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Hirsch1">[19]</xref>
###xml 22 28 <span type="species:ncbi:10090">murine</span>
A promoter region for murine p110gamma has also been identified [19]. Multiple transcriptional start sites exist for p110gamma, resulting in transcripts with varying 5' untranslated regions (5'UTRs), up to 874 bp in length. Analysis of the genomic p110gamma DNA up to 1.2 kb upstream from the transcription start site revealed that the putative promoter region contains consensus sites for housekeeping TFs such as AP1 and SP1, as well as several putative binding sites for leukocyte-specific TFs [19]. Functional analysis of this p110gamma putative promoter region revealed enhanced promoter activity in the U937 myeloid cell line compared to the HeLa epithelial cell line [19].
###end p 14
###begin p 15
###xml 1007 1013 987 993 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3CD</italic>
###xml 328 333 <span type="species:ncbi:10090">mouse</span>
###xml 338 343 <span type="species:ncbi:9606">human</span>
###xml 635 640 <span type="species:ncbi:10090">mouse</span>
###xml 689 694 <span type="species:ncbi:9606">human</span>
In this study, we have investigated the regulation of p110delta gene expression. We have documented that p110delta protein expression largely correlates with the level of p110delta mRNA in numerous cell types, indicating that p110delta expression is predominantly regulated at the level of transcription. We have found multiple mouse and human p110delta transcripts that contain distinct upstream untranslated exons, which we have named exon -1, -2a, -2b, -2c and -2d, located up to 81 kb upstream of the translational start codon in exon 1. Furthermore, we have identified a highly conserved TF-binding cluster that is located within mouse exon -2a and located immediately 5' upstream of human exon -2a. This TF-binding cluster has enhanced promoter activity in leukocytes compared to non-leukocytes. Out of the 7 different TF binding sites in the TF-binding cluster, 4 are associated with regulation of haematopoiesis and expression of leukocyte-specific genes. These findings are the first to identify a PIK3CD promoter and offer a rationale for the leukocyte-enriched expression of p110delta.
###end p 15
###begin title 16
Results
###end title 16
###begin title 17
p110delta protein expression is not altered in fibroblasts, B-lymphocytes and myelomonocytic cells upon acute stimulation with various agonists
###end title 17
###begin p 18
###xml 833 837 805 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Baier1">[48]</xref>
###xml 839 843 811 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Billottet1">[49]</xref>
We first investigated whether p110delta expression can be induced by several acute cellular stimuli. In NIH-3T3 fibroblasts, which contain very low levels of endogenous p110delta compared to leukocytes, p110delta could not be induced by TNF, the proteasome inhibitor PS-341, UV irradiation, osmotic stress or the glucocorticoid dexamethasone (data not shown). p110delta protein levels were also unaffected during different phases of the cell cycle in these cells (data not shown). In B lymphocytes, p110delta expression was not affected by stimulation of the antigen receptor using anti-IgM antibodies. In U937 myelomonocytic cells, p110delta levels were unaltered by treatment with retinoic acid, in contrast to the p110gamma protein which was induced effectively (data not shown), the latter in line with previously published data [48], [49]. Taken together, p110delta expression appears not to be regulated in an acute manner in response to extracellular stimuli, at least in the cell types and conditions investigated.
###end p 18
###begin title 19
Correlation between p110delta mRNA and protein levels in cell lines
###end title 19
###begin p 20
###xml 181 192 177 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g001">Figure 1A,B</xref>
###xml 323 327 315 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Geering1">[12]</xref>
###xml 329 333 321 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Vanhaesebroeck3">[13]</xref>
###xml 335 339 327 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Chantry1">[16]</xref>
###xml 341 345 333 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Sawyer1">[18]</xref>
###xml 479 483 467 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Geering1">[12]</xref>
###xml 152 158 <span type="species:ncbi:10090">murine</span>
###xml 163 168 <span type="species:ncbi:9606">human</span>
We next assessed the levels of p110delta protein and mRNA, using immunoblotting of total cell lysates and real time RT-PCR, respectively, in a panel of murine and human cell lines (Figure 1A,B). p110delta mRNA and protein were found in all cell lines investigated but in widely varying amounts. In line with published data [12], [13], [16], [18], leukocytes expressed high levels of p110delta while non-leukocytes expressed intermediate to low levels. In line with previous data [12], a good correlation was found between p110delta mRNA and protein levels in most cell lines tested, indicating that p110delta protein expression is mainly regulated at the level of transcription.
###end p 20
###begin title 21
###xml 68 74 <span type="species:ncbi:10090">murine</span>
###xml 79 84 <span type="species:ncbi:9606">human</span>
Correlation between p110delta protein and mRNA expression levels in murine and human cell lines.
###end title 21
###begin p 22
###xml 288 293 <span type="species:ncbi:10090">mouse</span>
###xml 298 303 <span type="species:ncbi:9606">human</span>
###xml 600 605 <span type="species:ncbi:10090">mouse</span>
###xml 630 635 <span type="species:ncbi:9606">human</span>
(A) Total cell lysates from the indicated cell lines were immunoblotted with antibodies to the distinct p110 isoforms or beta-actin. One representative immunoblot of three independent experiments is shown. The bars represent quantification of the relative amounts of p110delta protein in mouse and human cell lines, as determined in 3 independent experiments (for each cell line, the ratio of the OD of the p110delta immunoblot signal was determined, relative to that of beta-actin in this cell line. This value was then expressed relative to the p110delta/beta-actin ratio found in B16-BL6 (for the mouse lines) or HeLa (for the human lines). Values are averages of three independent experiments. (B) Quantification of p110delta mRNA levels by real time RT-PCR using primers in the p110delta coding region. Signals are normalised to beta-actin mRNA in each cell line. Data shown are the averages of three independent experiments.
###end p 22
###begin title 23
###xml 85 91 85 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3CD</italic>
DNA methylation and histone acetylation are unlikely to be key mechanisms to control PIK3CD expression
###end title 23
###begin p 24
###xml 208 212 208 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Geiman1">[50]</xref>
###xml 214 218 214 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Jenuwein1">[51]</xref>
###xml 685 689 678 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-VandenBerghe1">[52]</xref>
###xml 691 695 684 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Shestakova1">[53]</xref>
###xml 717 725 710 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g002">Figure 2</xref>
DNA methylation and histone acetylation are important epigenetic mechanisms that control gene expression by dictating transitions between transcriptionally active or transcriptionally silent chromatin states [50], [51]. L929 fibroblasts, which express low levels of p110delta mRNA and protein, were treated with 5'-azacytidine or trichostatin A, agents known to cause DNA (hemi-) demethylation and histone hyperacetylation, respectively, creating open configurations of genomic DNA to allow binding of TFs. As a positive control, we monitored the previously documented induction in these cells of mRNA expression of the cytokines IL-6 and IFN-beta by 5'-azacytidine and trichostatin A [52], [53]. As can be seen from Figure 2, p110delta mRNA expression levels were not dramatically altered by any of these treatments, with a maximum increase in p110delta mRNA of around 2-fold, which was not accompanied by an induction of p110delta protein expression.
###end p 24
###begin title 25
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
DNA methylation and histone acetylation do not alter p110delta expression in mouse L929 fibroblasts.
###end title 25
###begin p 26
(Top panel) L929 cells were treated with 5'-azacytidine (5AC,;5 microM) for 72 h and/or trichostatin A (TSA; 100 nM) for 6 h, with or without 6 h co-treatment with TNF (100 IU/ml)). mRNA levels of p110delta, IL-6 and IFN-beta were quantified by real time RT-PCR. Samples were normalised for GAPDH and are relative to p110delta mRNA amounts in the unstimulated samples (set as 1). Shown is the average of three independent experiments). (Lower panel) Representative immunoblot (of three) of p110delta protein.
###end p 26
###begin title 27
The presence of high p110delta mRNA levels is not a consequence of leukocyte-specific p110delta mRNA stability
###end title 27
###begin p 28
###xml 159 166 155 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 251 260 247 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g003">Figure 3A</xref>
###xml 679 688 663 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g003">Figure 3B</xref>
To assess whether high expression of the p110delta protein in cells is due to increased mRNA stability, cells were treated with Actinomycin D, an inhibitor of de novo RNA synthesis, followed by measurement of mRNA decay over time. As can be seen from Figure 3A, leukocyte (A20 and EL4) and non-leukocyte (B16-BL6, 3LL and NIH-3T3) cell lines displayed very similar rates of mRNA degradation upon inhibition of mRNA synthesis, indicating that there is no difference in p110delta mRNA stability between cell types expressing high or low levels of p110delta protein. Also p110delta protein levels were not affected by Actinomycin D treatment, both in leukocytes and non-leukocytes (Figure 3B).
###end p 28
###begin title 29
Equal p110delta mRNA stability in leukocytes and non-leukocytes.
###end title 29
###begin p 30
###xml 88 95 84 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
The indicated cell lines were treated with Actinomycin D (4 microg/ml), an inhibitor of de novo RNA synthesis, for the indicated time points followed by quantification of either p110delta mRNA (A) or p110delta protein (B). p110delta mRNA was quantified by real time RT-PCR, using normalisation for 18S RNA. p110delta mRNA levels are presented in a semi-log plot.
###end p 30
###begin title 31
Identification of multiple distinct p110delta mRNA transcripts with alternate first 5' untranslated exons
###end title 31
###begin p 32
###xml 25 31 25 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3CD</italic>
###xml 406 415 398 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g004">Figure 4A</xref>
###xml 584 588 576 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Vanhaesebroeck3">[13]</xref>
###xml 590 594 582 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Clayton1">[54]</xref>
###xml 933 939 925 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3CD</italic>
###xml 662 668 <span type="species:ncbi:10090">murine</span>
###xml 713 718 <span type="species:ncbi:9606">human</span>
###xml 840 845 <span type="species:ncbi:10090">mouse</span>
###xml 898 903 <span type="species:ncbi:9606">human</span>
###xml 917 922 <span type="species:ncbi:10090">mouse</span>
###xml 927 932 <span type="species:ncbi:9606">human</span>
In order to identify the PIK3CD promoter, we set out to identify the transcriptional start site of the p110delta mRNA. Rapid amplification of 5' cDNA ends (5'RACE) was used to identify the 5'UTR. BLAT alignment of the 5'RACE products led to three main observations: (1) multiple distinct p110delta transcripts exist within each cell line investigated; (2) most transcripts contains two untranslated exons (Figure 4A), which we have named exon -1 and -2 (to indicate their relative locations with respect to exon 1, which contains the putative ATG translation start site as defined in [13], [54]). The -1 and -2 exons are located 11 kb and >35 kb 5' of exon 1 in murine cells, and 19 kb and >59 kb 5' of exon 1 in human cells; (3) exon -1 can occur together with one of 4 identified second untranslated exons (exons -2a, -2b, -2c or -2d) in mouse cells, and with one of two -2 exons (-2a or -2b) in human cells. Thus, mouse and human PIK3CD can give rise to at least 4 and 2, respectively, distinct p110delta transcripts.
###end p 32
###begin title 33
PIK3CD transcripts, assessed by 5'RACE and database analysis.
###end title 33
###begin p 34
###xml 404 410 396 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3CD</italic>
###xml 131 137 <span type="species:ncbi:10090">murine</span>
###xml 142 147 <span type="species:ncbi:9606">human</span>
###xml 537 542 <span type="species:ncbi:10090">mouse</span>
###xml 547 552 <span type="species:ncbi:9606">human</span>
(A) Top panel, Schematic representation of the different p110delta mRNA transcripts in their genomic context as found by 5'RACE in murine and human cell lines. Bottom panel, the different p110delta transcripts as found in the Ensembl database (release 52, 9 December 2008) for both species. Arrowheads indicate -2 exons present in the database which we have not found by 5'RACE. Asterisks indicate short PIK3CD transcripts (which do not encode full length p110delta protein) found in the Ensembl database. (B) Region of homology between mouse and human exon -2a. Exons 1 which contain the transcription start sites are indicated with a vertical arrow.
###end p 34
###begin p 35
###xml 159 166 151 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005145.s001">File S1</xref>
###xml 344 350 332 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3CD</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 10 15 <span type="species:ncbi:10090">mouse</span>
Human and mouse p110delta exon 1 contains an in-frame stop codon immediately upstream of the p110delta start codon (for sequences, see Supporting Information, File S1), ruling out the possibility that the newly identified upstream exons are translated as part of the p110delta protein. In other words, the -1 and -2 exons form the 5'UTR of the PIK3CD transcripts.
###end p 35
###begin p 36
###xml 151 160 151 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g004">Figure 4B</xref>
###xml 479 488 479 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g004">Figure 4B</xref>
###xml 27 32 <span type="species:ncbi:9606">human</span>
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
###xml 163 168 <span type="species:ncbi:9606">Human</span>
###xml 214 219 <span type="species:ncbi:10090">mouse</span>
###xml 320 325 <span type="species:ncbi:10090">mouse</span>
###xml 404 409 <span type="species:ncbi:9606">human</span>
###xml 463 468 <span type="species:ncbi:10090">mouse</span>
###xml 521 526 <span type="species:ncbi:9606">human</span>
###xml 531 536 <span type="species:ncbi:10090">mouse</span>
###xml 608 613 <span type="species:ncbi:9606">human</span>
###xml 663 668 <span type="species:ncbi:10090">mouse</span>
The -1 exons identified in human and mouse show a high degree of homology (data not shown) and likewise the -2a exons share a region of high homology (Figure 4B). Human exon -2a is approximately half the length of mouse exon -2a (72 bp compared to 144 bp), and its first part (1-49 bp) is homologous to the last part of mouse exon -2a (96-144 bp). Interestingly, the intronic DNA immediately upstream of human exon -2a is highly homologous with the first part of mouse exon -2a (Figure 4B). In contrast the -2b exons for human and mouse are not homologous, which may indicate that the -2b exon identified in human may not be the equivalent -2b exon identified in mouse.
###end p 36
###begin p 37
###xml 250 259 250 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g004">Figure 4B</xref>
###xml 146 151 <span type="species:ncbi:10090">mouse</span>
###xml 168 173 <span type="species:ncbi:9606">human</span>
###xml 214 219 <span type="species:ncbi:10090">mouse</span>
###xml 312 317 <span type="species:ncbi:10090">mouse</span>
###xml 322 327 <span type="species:ncbi:9606">human</span>
Database information provides independent confirmation of several of the untranslated exons identified in this study (-1, -2a, -2b and -2c in the mouse; and -1, -2a in human), as well as additional -2 exons in the mouse (labeled with an arrowhead in Figure 4B) which we have thus far not found by 5'RACE both in mouse and human (>50 independent 5'RACE products sequenced; detailed data not shown).
###end p 37
###begin p 38
###xml 290 294 278 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Vanhaesebroeck3">[13]</xref>
###xml 671 678 651 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005145-t001">Table 1</xref>
###xml 274 279 <span type="species:ncbi:9606">human</span>
###xml 577 582 <span type="species:ncbi:10090">mouse</span>
###xml 1227 1232 <span type="species:ncbi:10090">mouse</span>
The p110delta transcripts identified by 5'RACE always contained exon -1, and further incorporated a single -2 exon in all cases. We have found two instances where the -1/-2 exon of the p110delta mRNA configuration does not seem to occur. Firstly, during the cDNA cloning of human p110delta [13], we identified one clone (called o5) which did not contain exon -1, and which has exon -2a directly spliced onto exon 1, giving rise to a p110delta transcript that encodes full length p110delta protein (data not shown). Secondly, 2 out of 48 transcripts identified by 5'RACE in the mouse EL4 leukocyte cell line did not have -2 exons, and started with an exon -1. As shown in Table 1, all -2 and -1 exons contain a classical splice donor sequence (GT), whereas exon -1 only contains a splice acceptor sequence (AG). This is in line with the observation that each p110delta transcript identified by 5'RACE contains a single -2 exon and further indicates that the different p110delta transcripts arise individually and not from a 'master' p110delta transcript by alternative splicing. The presence of a splice acceptor sequence in exon -1 indicates that the p110delta transcript starting at this exon (as revealed by 5'RACE) found in mouse EL4 cells could in fact be an artefact, due to RNA degradation during the RACE experiments.
###end p 38
###begin title 39
###xml 59 65 59 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3CD</italic>
Splice donor and acceptor sites in the 5' introns/exons of PIK3CD.
###end title 39
###begin p 40
###xml 105 114 101 110 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">top panel</bold>
###xml 128 139 124 135 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lower panel</bold>
###xml 98 103 <span type="species:ncbi:9606">human</span>
###xml 120 126 <span type="species:ncbi:10090">murine</span>
Splice donor and acceptor sites in p110delta exons. Splice acceptor and splice donor sequences of human (top panel) and murine (lower panel) p110delta exons. The untranslated exons as well as exons 1 and 2 are represented. Uppercase letters represent exon sequences, lowercase letters represent intron sequences. AG/GT splice donor/acceptor sequences are in bold. All other coding exons of p110delta follow the same AG/GT splicing rule (not shown).
###end p 40
###begin title 41
###xml 41 47 41 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3CD</italic>
Cell type-specific usage of the multiple PIK3CD transcription start sites
###end title 41
###begin p 42
###xml 376 385 372 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g005">Figure 5A</xref>
###xml 163 169 <span type="species:ncbi:10090">murine</span>
We next used RT-PCR to confirm the presence of the different p110delta transcripts identified by 5'RACE and to determine which of these can be found in a panel of murine leukocyte and non-leukocyte cell lines. Forward primers, specific for each of the 5' untranslated exons were designed, and used in combination with a common reverse primer in exon 2 (schematically shown in Figure 5A). PCR products of the predicted size were purified by agarose gel electrophoresis and verified by DNA sequencing (data not shown).
###end p 42
###begin title 43
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3CD</italic>
###xml 22 28 <span type="species:ncbi:10090">murine</span>
PIK3CD transcripts in murine cell lines and tissues, as assessed by RT-PCR
###end title 43
###begin p 44
###xml 75 81 75 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3CD</italic>
###xml 68 74 <span type="species:ncbi:10090">murine</span>
###xml 348 354 <span type="species:ncbi:10090">murine</span>
(A) Schematic representation of PCR primers used to detect distinct murine PIK3CD transcripts. In each case, a reverse primer in exon 2 and a forward primer in exon 1, -1, -2a, -2b, -2c or -2d, was used. (B) Agarose gel analysis of PCR products generated by RT-PCR (40 cycles) using primers for the different p110delta mRNA transcripts in panel of murine cell lines and tissues, with the observations summarized underneath.
###end p 44
###begin p 45
###xml 116 125 116 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g005">Figure 5B</xref>
###xml 277 283 269 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 366 375 358 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g005">Figure 5B</xref>
All cell lines tested (except CT26 colon carcinoma) expressed at least one type of transcript containing a -2 exon (Figure 5B). Leukocytes contained a broader variety of p110delta transcripts than non-leukocytes, with an average number of distinct p110delta transcripts of 4.3 versus 2.4 in leukocytes and non-leukocytes, respectively (summarized in bottom panel of Figure 5B).
###end p 45
###begin p 46
###xml 100 108 96 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g006">Figure 6</xref>
To more accurately quantify the amount of each p110delta transcript, we next used real time RT-PCR (Figure 6). For each transcript, the PCR reaction consisted of a forward and reverse primer, which were designed to amplify a cDNA sequence of approximately100 bp spanning an exon boundary specific to the transcript, and a dye-emitting probe, which bound at a sequence overlaying this exon boundary. During amplification of the cDNA sequence, cleavage of a reporter dye from the probe results in fluorescence emission, which can be directly correlated with the level of each particular p110delta transcript. For example, to measure the amount of p110delta transcripts containing exon -2a, a PCR was performed using a forward primer in exon -2a and a reverse primer in exon -1, while the dye-emitting probe bound at this exon-exon boundary. The fluorescence detected from this PCR reaction therefore represents the amount of all transcripts specifically containing exons -2a and -1.
###end p 46
###begin title 47
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3CD</italic>
###xml 22 28 <span type="species:ncbi:10090">murine</span>
PIK3CD transcripts in murine cell lines, as determined by real time PCR.
###end title 47
###begin p 48
###xml 77 83 <span type="species:ncbi:10090">murine</span>
Absolute quantification of the different p110delta transcripts in a panel of murine cell lines by real time RT-PCR (3 experiments) using primer mixes containing a forward primer in the first exon of each transcript, a reverse primer in the subsequent exon and a probe overlaying the exon/exon boundary. Copy numbers were calculated using a standard curve with the different transcripts cloned into a plasmid, and used as a control template for PCR. Samples were normalized to the levels of beta-actin mRNA. The different panels represent amplification of the boundaries of (A) exon 1/exon 2; (B) exon -1/exon 1; (C) exon -2a/exon -1 (D) exon -2b/exon -1 (E) exon -2c/exon -1 (F) exon -2d/exon -1.
###end p 48
###begin p 49
###xml 140 148 136 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g006">Figure 6</xref>
These experiments revealed that leukocytes express significantly higher amounts of the different p110delta transcripts than non-leukocytes (Figure 6), indicating that leukocytes are likely to be more efficient at using p110delta gene promoters than non-leukocytes.
###end p 49
###begin p 50
###xml 76 85 76 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g006">Figure 6A</xref>
###xml 227 236 227 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g006">Figure 6C</xref>
In all cell lines, the transcript containing the first coding exon (exon 1; Figure 6A) was expressed at similar levels as the transcript containing the exon -2a/exon -1 boundary, which is the most abundantly expressed -2 exon (Figure 6C).
###end p 50
###begin p 51
###xml 70 79 70 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g006">Figure 6B</xref>
###xml 169 178 169 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g006">Figure 6A</xref>
###xml 568 577 564 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g004">Figure 4A</xref>
###xml 752 756 748 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Buratowski1">[55]</xref>
###xml 757 761 753 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Seila1">[59]</xref>
Surprisingly, the transcripts containing the exon -1/exon 1 boundary (Figure 6B) were two-fold more abundant than the transcripts containing the exon 1/exon 2 boundary (Figure 6A). This indicates that shorter but still fully processed mRNAs (i.e. with a poly A tail since oligo d(T) was used for reverse transcription) are made. These would contain a 5'UTR with at least the untranslated exon -1 and the coding exon 1, but without any of the other coding exons. Database analysis also provided evidence for such shorter p110delta transcripts (marked with asterisks in Figure 4A). These may belong to the recently identified new class of mRNA transcripts that initiate near the expected transcription start sites, upstream of protein encoding sequences [55]-[59].
###end p 51
###begin title 52
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In silico</italic>
###xml 22 28 22 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3CD</italic>
In silico analysis of PIK3CD promoter
###end title 52
###begin p 53
###xml 87 93 87 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3CD</italic>
###xml 253 262 253 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g007">Figure 7A</xref>
###xml 288 295 288 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005145.s002">File S2</xref>
###xml 81 86 <span type="species:ncbi:10090">mouse</span>
Alignment of the genomic sequence of flanking (and including) the 5'UTR exons of mouse PIK3CD with 8 other species revealed high homology in specific areas, indicative for functionally conserved DNA sequences, including 4 CpG islands but no TATA boxes (Figure 7A; Supporting information, File S2).
###end p 53
###begin title 54
###xml 78 84 78 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3CD</italic>
Bioinformatic analysis of potential promoter elements and TF binding sites in PIK3CD.
###end title 54
###begin p 55
###xml 937 941 925 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Siepel1">[94]</xref>
###xml 1224 1230 1212 1218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3CD</italic>
###xml 36 42 <span type="species:ncbi:10090">murine</span>
###xml 104 110 <span type="species:ncbi:10090">murine</span>
###xml 204 209 <span type="species:ncbi:10090">mouse</span>
###xml 262 265 <span type="species:ncbi:10116">rat</span>
###xml 267 272 <span type="species:ncbi:9606">human</span>
###xml 289 292 <span type="species:ncbi:9615">dog</span>
###xml 294 297 <span type="species:ncbi:9913">cow</span>
###xml 310 318 <span type="species:ncbi:99490|species:ncbi:9783|species:ncbi:9785">elephant</span>
###xml 348 354 <span type="species:ncbi:10090">murine</span>
###xml 640 645 <span type="species:ncbi:10090">mouse</span>
###xml 1144 1149 <span type="species:ncbi:10090">mouse</span>
###xml 1337 1342 <span type="species:ncbi:9606">human</span>
###xml 1347 1352 <span type="species:ncbi:10090">mouse</span>
(A) Schematic representation of the murine p110delta 5'UTR. The upper panel shows the five untranslated murine p110delta exons (and exon 1) in their genomic context, with below (in descending order): the mouse RefSeq genes, CpG islands, homology with 9 species (rat, human, chimp, rhesus, dog, cow, armadillo, elephant, tenrec, plotted against the murine sequence) and the genomic fragments that were subcloned for use in gene reporter assays. (B) Locations of the conserved TF binding sites in the 600 bases (500 upstream to 100 downstream of the transcript start site) in the forward strand flanking the different 5'untranslated exons of mouse p110delta gene. The exon start sites are indicated by the vertical arrows, the TF binding sites found on the forward strand are shown as blue boxes above the TSS score graphs. Also shown is the degree of cross species (28 species) genomic conservation as calculated by the phastCons program [94] from a minimum of 0.0 to a maximum of 1.0. The genomic DNA fragments subcloned into the PGL3 reporter vector are shown underneath. (C) Alignment and conservation of the TF binding cluster identified in mouse exon -2a with genomic sequences upstream of the translation start site of PIK3CD of 7 other species. (D) Schematic representation of TF binding cluster location in relation to exon -2 in human and mouse.
###end p 55
###begin p 56
###xml 249 258 249 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g007">Figure 7B</xref>
###xml 419 425 419 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">within</italic>
###xml 436 448 436 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g007">Figure 7B, C</xref>
###xml 520 529 520 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g007">Figure 7C</xref>
###xml 554 563 554 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g007">Figure 7D</xref>
###xml 637 643 637 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">within</italic>
###xml 830 834 830 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-1">[60]</xref>
###xml 16 22 <span type="species:ncbi:10090">murine</span>
###xml 317 322 <span type="species:ncbi:10090">mouse</span>
###xml 469 474 <span type="species:ncbi:9606">human</span>
For each of the murine untranslated exons, the region spanning 500 bp upstream and 100 bp downstream of the first nucleotide were analysed for TF-binding sites and the transcription start site (TSS) prediction score within this region was assessed (Figure 7B). TF-binding sites were identified in the vicinity of all mouse untranslated exons, however a particularly condensed cluster of TF-binding sites was identified within exon -2a (Figure 7B, C). Interestingly, in human, this TF-binding cluster lies 5' of the TSS (Figure 7C; schematically shown in Figure 7D). It is unusual, but not unheard of, that promoter regions are contained within exons. Indeed, recent work from the ENCODE project ( and ) has revealed that proximal TF binding sites usually fall within 1 kb of both sides, 5' and 3', of the transcription start site [60].
###end p 56
###begin p 57
###xml 75 84 75 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g007">Figure 7A</xref>
###xml 145 154 145 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g007">Figure 7B</xref>
###xml 224 231 224 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005145.s002">File S2</xref>
###xml 233 242 233 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g007">Figure 7C</xref>
###xml 307 316 307 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g007">Figure 7D</xref>
###xml 633 642 633 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g007">Figure 7C</xref>
###xml 26 32 <span type="species:ncbi:10090">murine</span>
###xml 358 363 <span type="species:ncbi:9606">human</span>
###xml 368 373 <span type="species:ncbi:10090">mouse</span>
The TF-binding cluster of murine exon -2a was located within a CpG island (Figure 7A); was associated with a good TSS prediction score (0.9/1.0; Figure 7B) and was highly conserved across 28 species (Supporting information, File S2; Figure 7C shows the high degree homology of this region across 8 species, Figure 7D schematically shows the homology between human and mouse in this area). Collectively, these observations indicate the presence of a putative promoter region in/around exon -2a. Interestingly, 4 of the 7 different TFs identified within this binding cluster, namely ETS, IRF, NFAT and LEF (indicated by an asterisk in Figure 7C), have previously been associated with haematopoiesis and expression of leukocyte-specific genes (discussed in more detail below), suggesting that this TF-binding region may be involved in the high p110delta expression in leukocytes.
###end p 57
###begin title 58
###xml 32 38 32 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3CD</italic>
Functional analysis of putative PIK3CD promoter elements using reporter assays
###end title 58
###begin p 59
###xml 131 142 131 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g007">Figure 7A,B</xref>
###xml 173 176 173 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A&#8211;I</italic>
###xml 212 221 212 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g007">Figure 7B</xref>
###xml 236 237 236 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">J</italic>
###xml 340 350 340 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">luciferase</italic>
###xml 476 482 476 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3CD</italic>
###xml 573 577 573 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Ogilvy1">[61]</xref>
###xml 726 736 726 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">luciferase</italic>
###xml 57 62 <span type="species:ncbi:10090">mouse</span>
###xml 189 194 <span type="species:ncbi:10090">mouse</span>
###xml 590 594 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
We next cloned intronic genomic DNA sequences that flank mouse exons 1, -2a and -2b (including exons -2c and -2d) at their 5' end (Figure 7A,B; referred to as DNA fragments A-I) as well as mouse exon -2a itself (Figure 7B, DNA fragment J, which contains the TF-binding cluster), into the pGL3 reporter vector to drive expression of firefly luciferase. Vectors were transiently transfected in leukocyte and non-leukocyte cell lines and the promoter activities of the different PIK3CD DNA fragments were compared to that of the established leukocyte-specific promoter of Vav [61], and of the SV40 promoter, which is active in all cell types. The pGL3-Basic vector, which does not contain a promoter sequence upstream of firefly luciferase, was used to assess the basal level of luminescence.
###end p 59
###begin p 60
###xml 35 38 35 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A&#8211;I</italic>
###xml 145 154 145 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g008">Figure 8B</xref>
###xml 193 194 193 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">J</italic>
###xml 367 376 367 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g008">Figure 8C</xref>
###xml 438 441 438 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav</italic>
###xml 452 461 452 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g008">Figure 8C</xref>
###xml 667 670 667 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav</italic>
###xml 681 690 681 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g008">Figure 8C</xref>
###xml 767 776 767 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g006">Figure 6C</xref>
###xml 824 835 820 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g006">Figure 6D&#8211;F</xref>
###xml 196 201 <span type="species:ncbi:10090">mouse</span>
###xml 301 306 <span type="species:ncbi:10090">mouse</span>
The intronic genomic DNA fragments A-I did not possess significantly higher promoter activity in A20 leukocytes compared to NIH 3T3 fibroblasts (Figure 8B). This is in contrast to DNA fragment J (mouse exon-2a containing the TF-binding cluster) which had significantly higher promoter activity in the mouse macrophage cell line RAW 264.7 than in NIH 3T3 fibroblasts (Figure 8C), which was significantly higher than the leukocyte-specific Vav promoter (Figure 8C). The exon -2 fragment has also higher activity in the THP-1 monocytic cell line compared to the HEK293 (embryonic kidney) and CT26 (colon carcinoma) cell lines, again with higher activity compared to the Vav promoter (Figure 8C). Taken together with the relatively high abundance of the -2a transcripts (Figure 6C) over the other p110delta exon -2 transcripts (Figure 6D-F), these data indicate that the TF binding cluster of exon -2a is the predominant promoter of p110delta expression in leukocytes.
###end p 60
###begin title 61
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3CD</italic>
PIK3CD promoter analysis by reporter gene assays.
###end title 61
###begin p 62
###xml 44 50 44 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3CD</italic>
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A&#8211;I)</italic>
###xml 98 108 98 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">luciferase</italic>
###xml 202 207 202 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A&#8211;I)</italic>
###xml 326 332 326 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3CD</italic>
###xml 348 351 348 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav</italic>
###xml 493 499 493 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3CD</italic>
###xml 549 555 549 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 681 684 681 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vav</italic>
###xml 398 402 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 487 492 <span type="species:ncbi:10090">mouse</span>
###xml 731 735 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
(A) Schematic representation of the genomic PIK3CD DNA fragments (A-I) cloned upstream of firefly luciferase in the pGL3 reporter vector. (B) Promoter activity of each of the potential promoter regions (A-I) in A20 leukocytes and NIH-3T3 fibroblasts, as determined by luciferase reporter assays. The promoter activity of each PIK3CD region and the Vav promoter are expressed as a percentage of the SV40 promoter activity after subtraction of basal luminescence. (C) Promoter activity of mouse PIK3CD exon -2a DNA in leukocytes (RAW 264.7 and THP-1) versus non-leukocyte cell lines (NIH 3T3, HEK 293, and CT26), in two independent experiments. The promoter activity of exon -2a and Vav promoter are expressed as a percentage of the SV40 promoter activity after subtraction of basal luminescence. Each transfection was carried out in triplicate with the error bars indicating the standard deviation.
###end p 62
###begin title 63
Discussion
###end title 63
###begin p 64
###xml 269 275 261 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3CD</italic>
###xml 912 921 896 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g006">Figure 6A</xref>
###xml 927 936 911 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g006">Figure 6C</xref>
###xml 875 881 <span type="species:ncbi:10090">murine</span>
In this study, we have explored the mechanisms by which the well-documented leukocyte-enriched expression of p110delta might be achieved. We present evidence that p110delta expression is mainly regulated at the transcriptional level arising from different transcripts. PIK3CD transcription appears to be constitutive and not responsive to acute cellular stimuli, at least using the agonists tested in the three cell types (NIH 3T3 and L929 fibroblasts, primary B cells and U937 myelomonocytic cells) used in our study. All cell types can express the distinct p110delta mRNA transcripts but leukocytes express a greater diversity of transcripts and significantly higher amounts of the individual transcripts. In particular, the p110delta transcript containing the untranslated exon -2a, was expressed at similar levels to the transcript containing coding exon 1 in a panel of murine leukocyte cell lines (compare Figure 6A with Figure 6C), indicating that the majority of p110delta transcripts in a cell contain exon -2a.
###end p 64
###begin p 65
###xml 425 431 425 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3CD</italic>
###xml 615 621 615 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3CD</italic>
###xml 35 40 <span type="species:ncbi:10090">mouse</span>
###xml 189 194 <span type="species:ncbi:9606">human</span>
###xml 207 212 <span type="species:ncbi:9606">human</span>
###xml 525 530 <span type="species:ncbi:10090">mouse</span>
We have identified a region within mouse exon -2a that contains a cluster of TF-binding sites. This TF-binding cluster is highly conserved between species and found immediately upstream of human exon -2a in human. This TF binding cluster contains at least 4 leukocyte-related TFs sites and was found to display higher promoter activity in leukocyte cell lines compared to non-leukocyte cell lines. Given that the majority of PIK3CD transcripts contain exon -2a, these data indicate that the promoter region identified within mouse exon -2a is likely to be sufficient in mediating the majority of leukocyte-specific PIK3CD gene expression.
###end p 65
###begin p 66
###xml 282 286 282 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Bories1">[62]</xref>
###xml 287 291 287 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Wang1">[68]</xref>
###xml 460 464 460 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Ozato1">[69]</xref>
###xml 547 551 547 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Ozato1">[69]</xref>
###xml 553 557 553 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Paun1">[70]</xref>
###xml 685 689 685 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Rao1">[71]</xref>
###xml 745 749 745 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-DeBoer1">[72]</xref>
###xml 837 841 837 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Travis1">[73]</xref>
###xml 932 936 932 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Mombaerts1">[74]</xref>
###xml 937 941 937 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Leiden1">[79]</xref>
4 of the 7 TFs identified within this binding cluster, namely ETS, IRF, NFAT and LEF have previously been associated with regulation of haematopoiesis and expression of leukocyte-specific genes. Indeed, the ETS family of TFs play important roles in the regulation of haematopoiesis [62]-[68]. IRF family members are highly expressed, but not exclusively, in cells of the immune system and play a pivotal role in the induction of type I IFN signalling pathways [69], proinflammatory cytokines and expression of macrophage and B cell specific genes [69], [70]. NFAT family proteins are also mainly found in cells of the immune system, such as T cells, mast cells, NK cells and monocytes [71] and play a role in the regulation of various cytokines [72]. Finally, the LEF family of TFs, which are highly expressed in pre-B and T lymphocytes [73], have been linked to the regulation and expression of a number of lymphoid-specific genes [74]-[79].
###end p 66
###begin p 67
###xml 155 159 151 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Sawyer1">[18]</xref>
###xml 450 454 446 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Ayyanan1">[80]</xref>
###xml 455 459 451 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Ravindranath1">[83]</xref>
###xml 467 471 463 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Span1">[84]</xref>
###xml 473 477 469 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Furlan1">[85]</xref>
###xml 485 489 481 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Buggy1">[86]</xref>
###xml 500 504 496 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Zhang1">[87]</xref>
###xml 679 683 675 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Teschendorff1">[88]</xref>
High expression levels of p110delta are also frequently observed in some non-leukocyte cancer cell lines, such as in breast carcinoma, melanoma and glioma [18]. It is possible that cancer cells upregulate or aberrantly express TFs which are, in non-cancer cells, more specific for leukocytes. It is of interest to note that a number of the TFs that bind in the exon -2a cluster have indeed been implicated in breast cancer progression, including LEF [80]-[83], ETS-1 [84], [85], ETS-2 [86] and NFAT3 [87]. Recently, all four of these leukocyte-associated TF were identified as the most frequently differentially activated TFs in breast cancer based on a large microarray dataset [88].
###end p 67
###begin p 68
###xml 265 287 257 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g006">Figure 6B to Figure 6A</xref>
###xml 407 416 395 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g004">Figure 4A</xref>
###xml 635 639 623 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Core1">[56]</xref>
###xml 640 644 628 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Preker1">[58]</xref>
###xml 658 662 646 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Buratowski1">[55]</xref>
We have found evidence that, among the multiple p110delta transcripts, there may be mRNAs that do not encode full length p110delta. Indeed, transcripts containing the exon -1/exon 1 boundary are more abundant than those covering the exon 1/exon 2 boundary (compare Figure 6B to Figure 6A). Current database information supports the presence of such shorter p110delta transcripts (marked with an asterisk in Figure 4A). Indeed, several recent studies have reported the discovery of a new class of short promoter-associated RNA transcripts that initiate near the expected transcription start sites upstream of protein-encoding sequences [56]-[58] (reviewed in [55]). It remains to be seen whether these RNAs have a function, but their prevalence suggests that their synthesis may serve a functional role.
###end p 68
###begin p 69
###xml 264 268 260 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-1">[60]</xref>
###xml 221 226 <span type="species:ncbi:9606">human</span>
Further work is required to understand the precise mechanism of p110delta gene expression. The complexity of gene regulation has been exemplified by examination of 400 protein-coding genes in 1% (30 million bases) of the human genome as part of the ENCODE project [60], which revealed that 80% of these genes had additional exons, many of which were located thousands of bases away from the coding exons. Also many novel transcription start sites were found, many located thousands of bases away from the known start sites, while 25% of the promoters discovered were at the 3' end of the genes rather then at the 5' end. It is therefore highly likely that p110delta expression will be subject to additional levels of control rather than by simple proximal promoter elements.
###end p 69
###begin p 70
###xml 89 95 89 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PI3KCD</italic>
###xml 190 196 190 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3CD</italic>
###xml 347 353 347 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3CD</italic>
###xml 499 503 495 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Sawyer1">[18]</xref>
The data presented are the first to shed light onto the leukocyte-enriched expression of PI3KCD. Further investigations are needed to identify which TF-binding sites are critical in driving PIK3CD gene expression and whether cells of non-leukocyte origin, such as breast cancer cells, are able to utilize this putative promoter. Interference with PIK3CD expression at the promoter level may offer a novel therapeutic target in cases of aberrant p110delta overexpression, as observed in some cancers [18].
###end p 70
###begin title 71
Materials and Methods
###end title 71
###begin title 72
Antibodies and reagents
###end title 72
###begin p 73
###xml 182 187 <span type="species:ncbi:10090">mouse</span>
Antibodies to class IA PI3Ks were generated in-house or purchased from Santa Cruz Biotechnology (p110beta, sc-602). Cell culture reagents were purchased from Invitrogen, recombinant mouse TNF was provided by Peter Brouckaert (Ghent University, Belgium), other reagents were from Sigma: Actinomycin D (856258), 5'-azacytidine (A2358), trichostatin A (T8552), antibodies to beta-actin (A5441).
###end p 73
###begin title 74
RNA extraction, 5'Rapid Amplification of cDNA Ends (5'RACE), Reverse Transcription (RT)-Polymerase Chain Reaction (PCR) and Real Time RT-PCR
###end title 74
###begin p 75
Total RNA was extracted from cells using the RNeasy mini kit (Qiagen, 74104). mRNA was subsequently reverse transcribed using SuperScript II Reverse Transcriptase (Invitrogen, 18064) and oligo d(T) primers, and subsequently used in 5'RACE, RT-PCR or real time PCR.
###end p 75
###begin p 76
###xml 148 177 146 175 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CAGATCAGCTCCTCATTGGCACT-3&#8242;</named-content>
###xml 185 211 183 209 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCTTCTTCACGCGGTCGCCC-3&#8242;</named-content>
###xml 238 266 236 264 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ACTTGAACTTCCCCGTGTCCCG-3&#8242;</named-content>
###xml 274 302 272 300 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CGGGACACAGGGAAGTTCAGGT-3&#8242;</named-content>
###xml 451 479 445 473 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGCCAATGAGGAGGCTGATCTG-3&#8242;</named-content>
###xml 556 582 550 576 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CGTGGTTGTTGACTTCTTGC-3&#8242;</named-content>
###xml 597 625 591 619 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GAGAGCCAGGCAGAAGTGGGAT-3&#8242;</named-content>
###xml 641 669 635 663 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GAAGTGGAGTGTGCGGACTGTC-3&#8242;</named-content>
###xml 685 713 679 707 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCATCAACTCCTGCCCTGTGTG-3&#8242;</named-content>
###xml 729 757 723 751 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCCATGCTATCGGGAACTTGAG-3&#8242;</named-content>
###xml 773 801 767 795 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CAGAGTGCTTCCGGTGGTATCC-3&#8242;</named-content>
###xml 900 928 890 918 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CGGGACACAGGGAAGTTCAGGT-3&#8242;</named-content>
###xml 999 1026 989 1016 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TAAGGAGTCAGGCCAGGGCGG-3&#8242;</named-content>
###xml 1042 1068 1032 1058 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGTCGCTCCGAGCGGCCGCG-3&#8242;</named-content>
###xml 1083 1110 1073 1100 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CGAGGTTGGGAGAGGAGTGTG-3&#8242;</named-content>
###xml 141 147 <span type="species:ncbi:10090">murine</span>
###xml 179 184 <span type="species:ncbi:9606">human</span>
###xml 231 237 <span type="species:ncbi:10090">murine</span>
###xml 268 273 <span type="species:ncbi:9606">human</span>
###xml 378 383 <span type="species:ncbi:10090">mouse</span>
###xml 817 822 <span type="species:ncbi:9606">human</span>
For 5'RACE, the FirstChoice(R) RLM-RACE kit (Ambion, 1700) was used following the manufacturer's protocol using the following outer primers: murine 5'-CAGATCAGCTCCTCATTGGCACT-3', human 5'-GCTTCTTCACGCGGTCGCCC-3' and inner primers: murine 5'-ACTTGAACTTCCCCGTGTCCCG-3', human 5'-CGGGACACAGGGAAGTTCAGGT-3'. Products were cloned into pGEM-Teasy (Promega) for sequencing. RT-PCR for mouse p110delta was carried out using a common reverse primer in exon 2 (5'-TGCCAATGAGGAGGCTGATCTG-3') in combination with exon-specific forward primers, as follows: for exon 1: 5'-CGTGGTTGTTGACTTCTTGC-3'; for exon -1: 5'-GAGAGCCAGGCAGAAGTGGGAT-3'; for exon -2a: 5'-GAAGTGGAGTGTGCGGACTGTC-3'; for exon -2b: 5'-GCATCAACTCCTGCCCTGTGTG-3'; for exon -2c: 5'-GCCATGCTATCGGGAACTTGAG-3'; for exon -2d: 5'-CAGAGTGCTTCCGGTGGTATCC-3'. For RT-PCR of human p110delta, the following primers were used: common reverse primer in exon 1: 5'-CGGGACACAGGGAAGTTCAGGT-3' in combination with the following exon-specific primers: for exon -1: 5'-TAAGGAGTCAGGCCAGGGCGG-3', for exon -2a: 5'-AGTCGCTCCGAGCGGCCGCG-3', for exon-2b: 5'-CGAGGTTGGGAGAGGAGTGTG-3'. RT-PCR products were cloned into pGEM-Teasy vector (Promega) and sequenced using the T7 primer.
###end p 76
###begin p 77
###xml 440 462 440 462 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TCGCGCCTAGCCTTGG-3&#8242;</named-content>
###xml 479 502 479 502 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGCATCAGCGGGCTTCA-3&#8242;</named-content>
###xml 529 556 529 556 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;CTCAGCTCCTTAGATGTCGGTC-3&#8242;</named-content>
###xml 628 659 628 659 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGTGTCTGTCCTGACTTCCTAAGAA-3&#8242;</named-content>
###xml 676 702 676 702 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CGGGCTTCATCCCACTTCTG-3&#8242;</named-content>
###xml 729 760 729 760 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- CAGCTCCTTAGATGTACTTCTACA-3&#8242;</named-content>
###xml 917 918 917 918 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
For real time RT-PCR amplification TaqMan Universal PCR Mastermix (4304437) and primer mixes containing a FAM reporter probe (TagMan Gene Expression Assay) were obtained from Applied Biosystems. SYBR Green (Qiagen, 204143) was used for quantifying 18S RNA. Exon-specific primer sets and probes were designed to identify transcripts containing exon -1, -2a, -2c and -2d. For exon -2a the following primer sequences were used; forward primer 5'-TCGCGCCTAGCCTTGG-3', reverse primer 5'-GGCATCAGCGGGCTTCA-3' and FAM reporter sequence 5'CTCAGCTCCTTAGATGTCGGTC-3'. For exon -2b the following primer sequences were used; forward primer 5'-AGTGTCTGTCCTGACTTCCTAAGAA-3', reverse primer 5'-CGGGCTTCATCCCACTTCTG-3' and FAM reporter sequence 5'- CAGCTCCTTAGATGTACTTCTACA-3'. For each transcript of interest, known amounts of plasmids with this transcript were used to create a standard curve. Real-time PCR generated a series of CT values (the PCR cycle at which amplification of each target gene is first detected) for endogenous and plasmid-born cDNA, which allowed for the determination of mRNA copy numbers for each individual gene.
###end p 77
###begin title 78
Western blot
###end title 78
###begin p 79
###xml 75 79 75 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Okkenhaug1">[89]</xref>
###xml 186 191 <span type="species:ncbi:10090">mouse</span>
###xml 233 239 <span type="species:ncbi:9986">rabbit</span>
Cells were lysed and immunoblotted for PI3K expression as described before [89]. Primary antibodies were detected using fluorescently-labeled species-specific secondary antibodies (anti-mouse IRDye 800-conjugated (Rockland) and anti-rabbit Alexa-Fluor 680-conjugated (Molecular Probes). Quantification was done using an Odyssey infrared scanner (LICOR) using the manufacturer's software. Signal intensities were normalized for an internal loading control such as beta-actin or GAPDH.
###end p 79
###begin title 80
###xml 56 62 56 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PIK3CD</italic>
Bioinformatic analysis of putative promoter elements in PIK3CD genes
###end title 80
###begin p 81
###xml 199 203 195 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Karolchik1">[90]</xref>
###xml 430 434 426 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Blanchette1">[91]</xref>
###xml 551 555 547 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Cartharius1">[92]</xref>
###xml 695 699 691 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Down1">[93]</xref>
###xml 62 68 <span type="species:ncbi:10090">murine</span>
###xml 156 161 <span type="species:ncbi:10090">Mouse</span>
The upstream sequences for the five untranslated exons of the murine p110delta gene were inspected within the February 2006 (NCBI build 36) assembly of the Mouse genome using the UCSC genome browser [90]. Regions spanning 500 bp upstream and 100 bp downstream of the first nucleotide of each exon were analysed. The corresponding multiple species alignment was extracted using the Vertebrate Multiz Alignment & Conservation track [91] within the UCSC genome browser. The alignments were then screened for conserved TF binding sites using MatInspector [92] and a vertebrate factors subset of a of a proprietary database of Genomatix. In addition the candidate regions were inspected with Eponine [93], a probabilistic method for detecting transcription start sites, using a threshold of 0.9.
###end p 81
###begin title 82
Reporter gene assays
###end title 82
###begin p 83
###xml 817 821 817 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005145-Ogilvy1">[61]</xref>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
###xml 666 670 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
PCR amplification of genomic DNA from C57Bl/6 mice was used to generate fragments for the reporter assays. The amplified PCR products were inserted into the pGL3 reporter vector (Promega). Transfections of NIH3T3 and A20 cells were performed using Qiagen Superfect or electroporation, respectively. Equal number of cells were washed and lysed, using Promega lysis buffer (to normalize for transfection efficiency) and then assayed for luciferase activity using the firefly luciferase substrate from Promega on the MicroBeta workstation (Perkin Elmer). The luciferase activity was normalized using a luciferase gene in a pGL3 reporter vector under the control of the SV40 promoter as well as a promoterless luciferase/pGL3 reporter vector. DNA of the lymphocyte-specific Vav promoter (construct HS21 mentioned in Ref. [61], which we cloned from the original beta-galactosidase reporter construct into a pGL2 luciferase reporter vector) was used as a positive control.
###end p 83
###begin title 84
Supporting Information
###end title 84
###begin p 85
###xml 53 59 <span type="species:ncbi:10090">murine</span>
###xml 69 74 <span type="species:ncbi:9606">human</span>
5' RACE product sequences Sequences of the different murine (Mm) and human (Hs) p110delta transcripts as identified by 5'RACE.
###end p 85
###begin p 86
(0.03 MB DOC)
###end p 86
###begin p 87
Click here for additional data file.
###end p 87
###begin p 88
###xml 104 110 <span type="species:ncbi:10090">murine</span>
###xml 115 120 <span type="species:ncbi:9606">human</span>
Annotated multiple species alignments. This file shows the conserved TF binding sites for the different murine and human p110delta mRNA transcripts as identified by 5' RACE.
###end p 88
###begin p 89
(0.19 MB DOC)
###end p 89
###begin p 90
Click here for additional data file.
###end p 90
###begin p 91
We dedicate this manuscript to Lizzie Verrall, who initiated this project and who was an inspiration to us all.
###end p 91
###begin p 92
###xml 144 152 144 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005145-g002">Figure 2</xref>
We thank Klaus Okkenhaug for his contribution to the early phase of this work, Wim Vanden Berghe for help with the design of the experiments of Figure 2, Dimitri Kioussis for the Vav promoter construct, Sarah Ogilvy for help with the reporter assays and Pedro Cutillas for critically reading the manuscript.
###end p 92
###begin title 93
References
###end title 93
###begin article-title 94
Synthesis and function of 3-phosphorylated inositol lipids.
###end article-title 94
###begin article-title 95
Phosphoinositide 3-kinases: a conserved family of signal transducers.
###end article-title 95
###begin article-title 96
Characterizing the Interactions between the Two Subunits of the p101/p110gamma Phosphoinositide 3-Kinase and Their Role in the Activation of This Enzyme by Gbeta gamma Subunits.
###end article-title 96
###begin article-title 97
The G[beta][gamma] Sensitivity of a PI3K Is Dependent upon a Tightly Associated Adaptor, p101.
###end article-title 97
###begin article-title 98
p84, a New G[beta][gamma]-Activated Regulatory Subunit of the Type IB Phosphoinositide 3-Kinase p110[gamma].
###end article-title 98
###begin article-title 99
Characterization of p87PIKAP, a novel regulatory subunit of phosphoinositide 3-kinase gamma that is highly expressed in heart and interacts with PDE3B.
###end article-title 99
###begin article-title 100
The p110beta isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110gamma.
###end article-title 100
###begin article-title 101
Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis.
###end article-title 101
###begin article-title 102
Phosphoinositide 3-Kinase p110{beta} Activity: Key Role in Metabolism and Mammary Gland Cancer but Not Development.
###end article-title 102
###begin article-title 103
Regulation of phosphoinositide 3-kinase expression in health and disease.
###end article-title 103
###begin article-title 104
###xml 48 52 <span type="species:ncbi:10090">mice</span>
Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110alpha subunit of phosphoinositide 3-kinase.
###end article-title 104
###begin article-title 105
Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers.
###end article-title 105
###begin article-title 106
P110delta, a novel phosphoinositide 3-kinase in leukocytes.
###end article-title 106
###begin article-title 107
###xml 29 33 <span type="species:ncbi:10090">mice</span>
Early embryonic lethality in mice deficient in the p110beta catalytic subunit of PI 3-kinase.
###end article-title 107
###begin article-title 108
###xml 43 48 <span type="species:ncbi:9606">human</span>
Cloning of a novel, ubiquitously expressed human phosphatidylinositol 3-kinase and identification of its binding site on p85.
###end article-title 108
###begin article-title 109
p110delta, a novel phosphatidylinositol 3-kinase catalytic subunit that associates with p85 and is expressed predominantly in leukocytes.
###end article-title 109
###begin article-title 110
Control of Axonal Growth and Regeneration of Sensory Neurons by the p110delta PI 3-Kinase.
###end article-title 110
###begin article-title 111
Regulation of breast cancer cell chemotaxis by the phosphoinositide 3-kinase p110delta.
###end article-title 111
###begin article-title 112
###xml 16 22 <span type="species:ncbi:10090">murine</span>
Analysis of the murine phosphoinositide 3-kinase gamma gene.
###end article-title 112
###begin article-title 113
Tumour biology. Weakening link to colorectal cancer?
###end article-title 113
###begin article-title 114
Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction.
###end article-title 114
###begin article-title 115
###xml 69 74 <span type="species:ncbi:10090">mouse</span>
Phosphoinositide 3-kinase gamma controls autonomic regulation of the mouse heart through Gi-independent downregulation of cAMP level.
###end article-title 115
###begin article-title 116
PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects.
###end article-title 116
###begin article-title 117
###xml 54 59 <span type="species:ncbi:9606">human</span>
Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase.
###end article-title 117
###begin article-title 118
The role of endothelial PI3Kgamma activity in neutrophil trafficking.
###end article-title 118
###begin article-title 119
Role of phosphatidylinositol 3-kinasegamma in the beta-cell: interactions with glucagon-like peptide-1.
###end article-title 119
###begin article-title 120
###xml 123 127 <span type="species:ncbi:10090">mice</span>
Impaired glucose-stimulated insulin secretion, enhanced intraperitoneal insulin tolerance, and increased beta-cell mass in mice lacking the p110gamma isoform of phosphoinositide 3-kinase.
###end article-title 120
###begin article-title 121
###xml 82 86 <span type="species:ncbi:10090">mice</span>
Protection from angiotensin II-mediated vasculotoxic and hypertensive response in mice lacking PI3Kgamma.
###end article-title 121
###begin article-title 122
Regulation of epidermal homeostasis and repair by phosphoinositide 3-kinase.
###end article-title 122
###begin article-title 123
Enhanced gene expression for phosphatidylinositol 3-kinase in the hypoglossal motoneurons following axonal crush.
###end article-title 123
###begin article-title 124
Differential regulation of the regulatory subunits for phosphatidylinositol 3-kinase in response to motor nerve injury.
###end article-title 124
###begin article-title 125
###xml 82 86 <span type="species:ncbi:10116">rats</span>
Upregulated function of phosphatidylinositol-3-kinase in genetically hypertensive rats: a moderator of arterial hypercontractility.
###end article-title 125
###begin article-title 126
###xml 87 91 <span type="species:ncbi:10116">Rats</span>
PI3-Kinase Upregulation and Involvement in Spontaneous Tone in Arteries From DOCA-Salt Rats: Is p110{delta} the Culprit?
###end article-title 126
###begin article-title 127
###xml 146 150 <span type="species:ncbi:10116">rats</span>
Phosphoinositide 3-kinase mediates enhanced spontaneous and agonist-induced contraction in aorta of deoxycorticosterone acetate-salt hypertensive rats.
###end article-title 127
###begin article-title 128
###xml 151 159 <span type="species:ncbi:9606">patients</span>
Defective regulation of phosphatidylinositol-3-kinase gene expression in skeletal muscle and adipose tissue of non-insulin-dependent diabetes mellitus patients.
###end article-title 128
###begin article-title 129
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human placental growth hormone increases expression of the p85 regulatory unit of phosphatidylinositol 3-kinase and triggers severe insulin resistance in skeletal muscle.
###end article-title 129
###begin article-title 130
###xml 44 49 <span type="species:ncbi:9606">human</span>
Regulation by insulin of gene expression in human skeletal muscle and adipose tissue. Evidence for specific defects in type 2 diabetes.
###end article-title 130
###begin article-title 131
###xml 113 118 <span type="species:ncbi:9606">Human</span>
Acute Regulation by Insulin of Phosphatidylinositol-3-kinase, Rad, Glut 4, and Lipoprotein Lipase mRNA Levels in Human Muscle.
###end article-title 131
###begin article-title 132
###xml 167 175 <span type="species:ncbi:9606">patients</span>
Expression of the splice variants of the p85alpha regulatory subunit of phosphoinositide 3-kinase in muscle and adipose tissue of healthy subjects and type 2 diabetic patients.
###end article-title 132
###begin article-title 133
Stat3-induced apoptosis requires a molecular switch in PI(3)K subunit composition.
###end article-title 133
###begin article-title 134
###xml 21 39 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Cell target genes of Epstein-Barr virus transcription factor EBNA-2: induction of the p55alpha regulatory subunit of PI3-kinase and its role in survival of EREB2.5 cells.
###end article-title 134
###begin article-title 135
SREBP1 regulates the expression of heme oxygenase 1 and the phosphatidylinositol-3 kinase regulatory subunit p55gamma.
###end article-title 135
###begin article-title 136
miR-29 miRNAs activate p53 by targeting p85alpha and CDC42.
###end article-title 136
###begin article-title 137
The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers.
###end article-title 137
###begin article-title 138
Mechanisms underlying p53 regulation of PIK3CA transcription in ovarian surface epithelium and in ovarian cancer.
###end article-title 138
###begin article-title 139
The forkhead transcription factor FOXO3a increases PI3K/Akt activity in drug-resistant leukaemic cells through induction of PIK3CA expression.
###end article-title 139
###begin article-title 140
Transcriptional regulation of PIK3CA oncogene by NF-kappaB in ovarian cancer microenvironment.
###end article-title 140
###begin article-title 141
Retinoic acid induces selective expression of phosphoinositide 3-kinase gamma in myelomonocytic U937 cells.
###end article-title 141
###begin article-title 142
Inhibition of Class I Phosphoinositide 3-Kinase Activity Impairs Proliferation and Triggers Apoptosis in Acute Promyelocytic Leukemia Without Affecting Atra-Induced Differentiation.
###end article-title 142
###begin article-title 143
Chromatin remodeling, histone modifications, and DNA methylation-how does it all fit together?
###end article-title 143
###begin article-title 144
Translating the histone code.
###end article-title 144
###begin article-title 145
The nuclear factor-kappaB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter.
###end article-title 145
###begin article-title 146
Inhibition of histone deacetylation induces constitutive derepression of the beta interferon promoter and confers antiviral activity.
###end article-title 146
###begin article-title 147
###xml 31 36 <span type="species:ncbi:10090">mouse</span>
Structural organization of the mouse phosphatidylinositol 3-kinase p110d gene.
###end article-title 147
###begin article-title 148
Transcription. Gene expression-where to start?
###end article-title 148
###begin article-title 149
###xml 78 83 <span type="species:ncbi:9606">human</span>
Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters.
###end article-title 149
###begin article-title 150
###xml 32 37 <span type="species:ncbi:9606">human</span>
The antisense transcriptomes of human cells.
###end article-title 150
###begin article-title 151
###xml 63 68 <span type="species:ncbi:9606">human</span>
RNA exosome depletion reveals transcription upstream of active human promoters.
###end article-title 151
###begin article-title 152
Divergent transcription from active promoters.
###end article-title 152
###begin article-title 153
###xml 71 76 <span type="species:ncbi:9606">human</span>
(2007) Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project.
###end article-title 153
###begin article-title 154
Transcriptional regulation of vav, a gene expressed throughout the hematopoietic compartment.
###end article-title 154
###begin article-title 155
Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene.
###end article-title 155
###begin article-title 156
###xml 22 28 <span type="species:ncbi:10090">murine</span>
###xml 100 108 <span type="species:ncbi:9606">patients</span>
Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia.
###end article-title 156
###begin article-title 157
###xml 32 36 <span type="species:ncbi:10090">mice</span>
Use of RDA analysis of knockout mice to identify myeloid genes regulated in vivo by PU.1 and C/EBPalpha.
###end article-title 157
###begin article-title 158
Defective activation and survival of T cells lacking the Ets-1 transcription factor.
###end article-title 158
###begin article-title 159
PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors.
###end article-title 159
###begin article-title 160
###xml 48 52 <span type="species:ncbi:10090">mice</span>
Defective B cell receptor-mediated responses in mice lacking the Ets protein, Spi-B.
###end article-title 160
###begin article-title 161
###xml 60 64 <span type="species:ncbi:10090">mice</span>
Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL.
###end article-title 161
###begin article-title 162
The interferon regulatory factor family in host defense: mechanism of action.
###end article-title 162
###begin article-title 163
The IRF family, revisited.
###end article-title 163
###begin article-title 164
NF-ATp: a transcription factor required for the co-ordinate induction of several cytokine genes.
###end article-title 164
###begin article-title 165
Role of nuclear factor of activated T cells (NFAT) in the expression of interleukin-5 and other cytokines involved in the regulation of hemopoetic cells.
###end article-title 165
###begin article-title 166
LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain, regulates T-cell receptor alpha enhancer function [corrected].
###end article-title 166
###begin article-title 167
###xml 16 20 <span type="species:ncbi:10090">mice</span>
RAG-1-deficient mice have no mature B and T lymphocytes.
###end article-title 167
###begin article-title 168
###xml 16 20 <span type="species:ncbi:10090">mice</span>
RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement.
###end article-title 168
###begin article-title 169
Lymphoid enhancer-binding factor-1 binds and activates the recombination-activating gene-2 promoter together with c-Myb and Pax-5 in immature B cells.
###end article-title 169
###begin article-title 170
###xml 20 26 <span type="species:ncbi:10090">murine</span>
###xml 42 47 <span type="species:ncbi:9606">human</span>
Identification of a murine homolog of the human adenosine deaminase thymic enhancer.
###end article-title 170
###begin article-title 171
###xml 82 88 <span type="species:ncbi:10090">murine</span>
Identification and characterization of a T-cell-specific enhancer adjacent to the murine CD4 gene.
###end article-title 171
###begin article-title 172
Transcriptional regulation of T-cell genes during T-cell development.
###end article-title 172
###begin article-title 173
###xml 57 62 <span type="species:ncbi:9606">human</span>
Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism.
###end article-title 173
###begin article-title 174
Beta-catenin/LEF-1 signalling in breast cancer-central players activated by a plethora of inputs.
###end article-title 174
###begin article-title 175
Beta-catenin and Tcfs in mammary development and cancer.
###end article-title 175
###begin article-title 176
The role of LEF/TCF factors in neoplastic transformation.
###end article-title 176
###begin article-title 177
Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer.
###end article-title 177
###begin article-title 178
Ets-1 triggers and orchestrates the malignant phenotype of mammary cancer cells within their matrix environment.
###end article-title 178
###begin article-title 179
###xml 51 56 <span type="species:ncbi:9606">human</span>
Ets2 transcription factor in normal and neoplastic human breast tissue.
###end article-title 179
###begin article-title 180
Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells.
###end article-title 180
###begin article-title 181
Elucidating the altered transcriptional programs in breast cancer using independent component analysis.
###end article-title 181
###begin article-title 182
###xml 81 85 <span type="species:ncbi:10090">mice</span>
Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice.
###end article-title 182
###begin article-title 183
The UCSC Genome Browser Database.
###end article-title 183
###begin article-title 184
Aligning multiple genomic sequences with the threaded blockset aligner.
###end article-title 184
###begin article-title 185
MatInspector and beyond: promoter analysis based on transcription factor binding sites.
###end article-title 185
###begin article-title 186
Computational detection and location of transcription start sites in mammalian genomic DNA.
###end article-title 186
###begin article-title 187
###xml 67 72 <span type="species:ncbi:4932">yeast</span>
Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes.
###end article-title 187
###begin p 188
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: Current and previous funding from PIramed, AstraZeneca and UCB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Personal support was from the AMC, Amsterdam, The Netherlands (KK), the Medical Research Council UK (EV, GEN) and the Ludwig Institute for Cancer Research (KK, GEN, EV, BV).
###end p 188

